about
Targeting the TAM Receptors in LeukemiaStrategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents.Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models.The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyProteasome inhibitors in acute leukemia.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.How I treat paediatric relapsed acute myeloid leukaemia.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.Novel approaches to pediatric leukemia treatment.Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia.Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.Increased p53 protein expression as a potential predictor of early relapse after hematopoietic stem cell transplantation in children with acute myelogenous leukemia.Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse.
P2860
Q28078654-5098AD8F-E574-48DC-8EE8-DC09A7EB4A9FQ30244244-696F4DB8-4A99-4D59-995C-878522E00416Q35210664-F073A114-A734-4DAC-9871-2CB96EF513FBQ35572018-4CCC92CF-D506-4B1E-B046-F0A786EE946DQ36036315-A6F28642-D8C4-4AB3-8138-8958241053B0Q36053792-F9FD5C31-AFDE-45DB-82EF-0AD7D7F14DA9Q36709867-5C4375E8-83F9-4846-B3B5-588BAC9F01DDQ37233146-6132FD4D-E6C8-4CD9-8325-7F77ABDA8064Q38088003-A19D55E5-0713-413C-B5A2-3C686C8096F1Q38155455-C0B53714-643D-4BD2-99E7-603BF064B840Q38195065-6B130EFF-80AB-4853-9472-8B74721F7FBBQ38212509-EFFF657D-46AA-4795-9D08-0193D06AE32EQ38253011-7DE8CAEC-41CA-4AD8-9C7A-B4ED997B84F1Q38500371-BFCAF7D0-0F67-4586-8847-1317AA53552CQ38662393-CFDDF356-F534-4349-87ED-B93661C7C543Q39967880-0D321358-340A-435D-AD34-67E811C40B09Q52912438-42FB7F3F-7C6E-4E36-9583-EB843AF8021CQ54342441-FD2DFA9F-6DCB-4EFF-ACD3-863F36F9FDDD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pediatric acute myeloid leukemia.
@en
Pediatric acute myeloid leukemia.
@nl
type
label
Pediatric acute myeloid leukemia.
@en
Pediatric acute myeloid leukemia.
@nl
prefLabel
Pediatric acute myeloid leukemia.
@en
Pediatric acute myeloid leukemia.
@nl
P2860
P356
P1476
Pediatric acute myeloid leukemia.
@en
P2093
Gertjan J L Kaspers
P2860
P304
P356
10.1586/ERA.12.1
P577
2012-03-01T00:00:00Z